Nevertheless, the efficacy of the NK-1R antagonist aprepitant has been explored in the treatment of CTCL pruritus and has shown a significant antipruritic effect in many case reports and case series [165–170] (Table 1). This evidence concerns the gene TACR1 and Pruritus.